What is the evidence basis for existing treatments of eating disorders?

@article{Bergh2003WhatIT,
  title={What is the evidence basis for existing treatments of eating disorders?},
  author={Cecilia Bergh and Jan Ejderhamn and Per S{\"o}dersten},
  journal={Current opinion in pediatrics},
  year={2003},
  volume={15 3},
  pages={
          344-5
        }
}
Most existing treatments of eating disorders (ED) produce a period of remission that is short lived and expressed in fewer than 50% of the patients. Antidepressants (eg, selective serotonin reuptake inhibitors [SSRI]) have a small effect in bulimia nervosa and they are not recommended in anorexia nervosa (AN) because serotonin inhibits food intake. In a randomized, controlled trial, training of eating behavior and satiety, supply of warmth, reduction of physical hyperactivity, and restoration… 
Anorexia nervosa: towards a neurobiologically based therapy.
Pharmacological Treatment of Anorexia Nervosa: A Retrospective Study in Preadolescents and Adolescents
TLDR
Combined with a multidisciplinary approach that includes nutritional rehabilitation and psychotherapy, adjunctive pharmacotherapy may be useful in addressing both eating disorder psychopathology and comorbid psychiatric disorders.
Genetic polymorphisms as a risk factor for anorexia nervosa.
TLDR
Current knowledge about the relationship between AN and polymorphism of substances known to be regulating eating behaviour or metabolic pathways e.g. serotonin, ghrelin, catechol-O-methyl transferase, neuropeptide Y, brain-derived neurotrophic factor and adipokines is summarized.
Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disorders
TLDR
The findings are consistent with previously reported data for patients with eating disorders and suggest the need for future studies using EEG data correlated with those from other patients with similar quantitative EEG features.
Psychopharmakologisches Wissen für die pädiatrische Praxis
TLDR
Psychopharmacological treatment is gaining importance in Germany as part of a multimodal child and adolescent psychiatric therapeutic approach and “off-label” use is common, especially in the treatment of impulsive aggression.
Psychopharmaka im Kindes- und Jugendalter
Die Psychopharmakotherapie besitzt inzwischen auch einen festen Stellenwert in der Kinder- und Jugendpsychiatrie. Die unterschiedlichen Leitlinien in der Kinder– und Jugendpsychiatrie benennen zu
Psychopharmakologisches Wissen für die pädiatrische Praxis Gängige Arzneimittel des Kinder- und Jugendpsychiaters
Immer wieder kommt es zu offentlichen Diskussionen uber Nutzen, Uberversorgung und Gefahrenpotenzial des Einsatzes von Psychopharmaka bei Kindern und Jugendlichen. Dabei sind eine Reihe von ihnen

References

SHOWING 1-10 OF 17 REFERENCES
Randomized controlled trial of a treatment for anorexia and bulimia nervosa
TLDR
It is suggested that most patients treated with this method recover, because the risk of relapse is maximal in the first year after remission, and the estimated rate of remission was 75%, and estimated time to remission was 14.7 months.
Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?
TLDR
These results suggest that SSRI medication had no effect on clinical symptoms of malnourished underweight anorexics.
Family and individual therapy in anorexia nervosa. A 5-year follow-up.
TLDR
Much of the improvements found at a 5-year follow-up can be attributed to the natural outcome of the illness, Nevertheless, it was still possible to detect long-term benefits of psychological therapies completed 5 years previously.
Practice guideline for the treatment of patients with eating disorders (revision)
TLDR
These guidelines contain the clinical factors that need to be considered when treating a patient with anorexia nervosa or bulimia nervosa and choose a site of treatment depending on the patient's general medical status.
Effects of SSRIs on sexual function: a critical review.
TLDR
The effects of SSRIs on sexual functioning seem strongly dose-related and may vary among the group according to serotonin and dopamine reuptake mechanisms, induction of prolactin release, anticholinergic effects, inhibition of nitric oxide synthetase, and propensity for accumulation over time.
Relapse predictors of patients with bulimia nervosa who achieved abstinence through cognitive behavioral therapy.
TLDR
The predictors of relapse found in this study can be readily determined by clinicians and the effectiveness of early additional treatment interventions needs to be determined with well-designed studies of large samples.
Heat in the treatment of patients with anorexia nervosa
TLDR
The paper presents the results of heat treatment in three cases of anorexia nervosa, in which marked overactivity and/or strenuous exercising were prominent clinical features, and the outcomes went far beyond what had been expected.
...
1
2
...